How to buy Tilray shares

Own Tilray shares in just a few minutes.

Updated

Fact checked

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Tilray, Inc is a drug manufacturers-specialty & generic business with stocks listed in the US. Tilray shares (TLRY) are listed on the NASDAQ and all prices are listed in US Dollars. Here's how to invest if you're based in Australia.

How to buy shares in Tilray

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Tilray. Find the share by name or ticker symbol: TLRY. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Tilray reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Tilray, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Tilray. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

Tilray share price

Use our graph to track the performance of TLRY stocks over time.

Tilray shares at a glance

Information last updated 2021-02-23.
52-week rangeUS$2.43 - US$55.01
50-day moving average US$22.4976
200-day moving average US$10.7543
Target priceUS$18.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) US$-1.23

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data updated regularly
Name Product Standard brokerage for US shares Inactivity fee Currency conversion fee Markets
eToro Share Trading (US stocks)
USD 0
USD 10 per month if there’s been no login for 12 months
0.50%
Forex, CFDs, US shares
Zero brokerage share trading on US stocks with trades as low as $50.
Note: This broker offers CFDs which are volatile investment products and most clients lose money trading CFDs with this provider.
Join the world’s biggest social trading network when you trade stocks, commodities and forex from the one account.
CMC Markets Stockbroking
USD 0
No
0.60%
ASX shares, Global shares, Forex, CFDs, Options trading, mFunds, ETFs, Warrants
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, managed funds, forex, commodities and cryptocurrencies, plus access up to 15 major global and Australian stock exchanges.
IG Share Trading
Finder Award
IG Share Trading
USD 0
AUD 50 per quarter if you make fewer than three trades in that period
0.70%
ASX shares, Global shares, Forex, CFDs, Margin trading
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Note: $10,000 deposit required to open account.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, forex and CFDs, plus get access to 24-hour customer support.
loading

Compare up to 4 providers

Is it a good time to buy Tilray stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Tilray financials

Revenue TTM US$191.3 million
Gross profit TTM US$25.2 million
Return on assets TTM -8.76%
Return on equity TTM -82.25%
Profit margin -141.67%
Book value 2.36
Market capitalisation US$4.3 billion

TTM: trailing 12 months

Shorting Tilray shares

There are currently 30.8 million Tilray shares held short by investors – that's known as Tilray's "short interest". This figure is 10.5% down from 34.4 million last month.

There are a few different ways that this level of interest in shorting Tilray shares can be evaluated.

Tilray's "short interest ratio" (SIR)

Tilray's "short interest ratio" (SIR) is the quantity of Tilray shares currently shorted divided by the average quantity of Tilray shares traded daily (recently around 34.6 million). Tilray's SIR currently stands at 0.89. In other words for every 100,000 Tilray shares traded daily on the market, roughly 890 shares are currently held short.

However Tilray's short interest can also be evaluated against the total number of Tilray shares, or, against the total number of tradable Tilray shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tilray's short interest could be expressed as 0.19% of the outstanding shares (for every 100,000 Tilray shares in existence, roughly 190 shares are currently held short) or 0.2045% of the tradable shares (for every 100,000 tradable Tilray shares, roughly 205 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tilray.

Find out more about how you can short Tilray stock.

Tilray share dividends

We're not expecting Tilray to pay a dividend over the next 12 months.

Tilray share price volatility

Over the last 12 months, Tilray's shares have ranged in value from as little as US$2.43 up to US$55.01. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tilray's is 2.8296. This would suggest that Tilray's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Tilray overview

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, Israel, Ireland, New Zealand, South Africa, Switzerland, the United States, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site